Clinical Trials Directory

Trials / Completed

CompletedNCT00643656

Use of 50% Nitrous Oxide / 50% Oxygen Premix During Liver Biopsy of Focal Lesion

Study of the Efficiency of Kalinox 170 Bar During Liver Biospy of Focal Lesion

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
94 (estimated)
Sponsor
Air Liquide Santé International · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A 50% nitrous oxide / 50% oxygen premix is administrated to the patient during the realization of liver biopsy in order to relax him and to reduce his pain during this painful medical treatment. This single investigator centre and national clinical trial is done blindly : half of patients will receive 50% nitrous oxide / 50% oxygen premix and half of them a placebo gas (mixture of 50% oxygen and 50% nitrogen). 94 patients will be included in this clinical protocol.

Conditions

Interventions

TypeNameDescription
DRUGKalinox 170 barFlow of gas administrated to the patient between 4 and 15 litre/min and less than 1 hour
DRUGMix of 50% oxygen and 50% nitrogenFlow of gas administrated to the patient between 4 and 15 litre/min and less than 1 hour

Timeline

Start date
2007-10-01
Primary completion
2008-06-01
Completion
2008-12-01
First posted
2008-03-26
Last updated
2025-03-13

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00643656. Inclusion in this directory is not an endorsement.